Consequently, we hypothesized that hyperimmune GPCMV(PC+) convalescent animals with similar response as a PC+ DISC vaccine would have high-level protection against heterologous TAMYC strain virus challenge
Consequently, we hypothesized that hyperimmune GPCMV(PC+) convalescent animals with similar response as a PC+ DISC vaccine would have high-level protection against heterologous TAMYC strain virus challenge. animals but not when challenged with TAMYC strain. GPCMV studies with AdgB vaccine sera on numerous cell-types exhibited impaired neutralization (NA50) compared to fibroblasts.…